当前位置:首页 - 行情中心 - 仁度生物(688193) - 财务分析 - 现金流量表

仁度生物

(688193)

  

流通市值:20.70亿  总市值:20.70亿
流通股本:4006.99万   总股本:4006.99万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金136,587,362.183,942,045.2541,469,296.46201,156,012.1
  收到的税费返还4,859.644,859.644,859.64-
  收到其他与经营活动有关的现金3,246,369.62,490,300.07660,335.739,857,541.82
  经营活动现金流入小计139,838,591.3486,437,204.9642,134,491.83211,013,553.92
  购买商品、接受劳务支付的现金19,160,845.0510,087,474.935,439,724.4221,545,713.03
  支付给职工以及为职工支付的现金58,802,412.8242,362,599.724,398,121.6483,314,312.22
  支付的各项税费11,423,288.916,235,130.731,043,902.896,896,177.77
  支付其他与经营活动有关的现金44,692,638.7128,793,939.3914,097,297.5974,870,143.5
  经营活动现金流出小计134,079,185.4987,479,144.7544,979,046.54186,626,346.52
  经营活动产生的现金流量净额5,759,405.85-1,041,939.79-2,844,554.7124,387,207.4
二、投资活动产生的现金流量:
  收回投资收到的现金1,393,000,0001,125,000,000475,000,0001,390,000,000
  取得投资收益收到的现金5,789,824.724,651,748.211,509,753.7711,174,071.57
  处置固定资产、无形资产和其他长期资产收回的现金净额4,600--1,115,704.78
  投资活动现金流入小计1,398,794,424.721,129,651,748.21476,509,753.771,402,289,776.35
  购建固定资产、无形资产和其他长期资产支付的现金1,500,981.63906,926.83599,426.8310,524,534.42
  投资支付的现金1,513,969,827.681,155,516,052.62405,516,757.621,713,753,600
  投资活动现金流出小计1,515,470,809.311,156,422,979.45406,116,184.451,724,278,134.42
  投资活动产生的现金流量净额-116,676,384.59-26,771,231.2470,393,569.32-321,988,358.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,627,112---
  收到其他与筹资活动有关的现金65,256---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计2,692,368---
  分配股利、利润或偿付利息支付的现金3,870,857.23,870,857.2-11,710,023.4
  支付其他与筹资活动有关的现金2,128,872.751,490,213.64703,907.4438,933,689.58
  筹资活动现金流出小计5,999,729.955,361,070.84703,907.4450,643,712.98
  筹资活动产生的现金流量净额-3,307,361.95-5,361,070.84-703,907.44-50,643,712.98
四、汇率变动对现金及现金等价物的影响847,065.72469,801.83500,248.19556,833.03
五、现金及现金等价物净增加额-113,377,274.97-32,704,440.0467,345,355.36-347,688,030.62
  加:期初现金及现金等价物余额261,577,985.82261,577,985.82261,577,985.82609,266,016.44
  期末现金及现金等价物余额148,200,710.85228,873,545.78328,923,341.18261,577,985.82
补充资料:
  净利润-2,037,965.98--7,812,187.82
  资产减值准备-905,130-17,066,988.49
  固定资产和投资性房地产折旧-7,028,991.8-14,120,276.78
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,028,991.8-14,120,276.78
  无形资产摊销-111,110.89-220,265.64
  长期待摊费用摊销-1,499,197.46-2,433,712.51
  处置固定资产、无形资产和其他长期资产的损失--7,322.72--136,347.79
  固定资产报废损失-16,800.1-826,634.3
  公允价值变动损失--1,985,862.02-237,263.21
  财务费用-234,755.6-304,847.14
  投资损失--4,904,494.32--11,174,071.57
  递延所得税--1,273,582.67--7,284,232.7
  其中:递延所得税资产减少--1,273,582.67--7,284,232.7
  存货的减少-1,065,889.64-2,487,769.97
  经营性应收项目的减少-7,710,922.99-9,449,846.95
  经营性应付项目的增加--14,563,579.69--4,134,023.32
  其他--575,074.57-2,278,449.18
  现金的期末余额-228,873,545.78-261,577,985.82
  减:现金的期初余额-261,577,985.82-609,266,016.44
  现金及现金等价物的净增加额--32,704,440.04--347,688,030.62
公告日期2025-10-312025-08-302025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑